This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Julius-Maximilians-Universitat Wurzburg. Active years: 2010-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Veitshochheim, DE (2010)
- Veitshöchheim, DE (2020 - 2024)
Company Filing History:
Years Active: 2010-2024
Title: Thomas Müller: Innovator in Monoclonal Antibodies
Introduction
Thomas Müller is a distinguished inventor based in Veitshöchheim, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of two patents to his name, Müller is recognized for his innovative approaches to medical science.
Latest Patents
Müller's latest patents focus on monoclonal antibodies to growth and differentiation factor 15 (GDF-15). The first patent describes novel monoclonal anti-human-GDF-15 antibodies, along with pharmaceutical compositions, kits, methods, and uses. It also includes cell lines capable of producing these monoclonal antibodies. Furthermore, this invention relates to antibodies that can inhibit cancer growth, showcasing Müller's commitment to advancing cancer treatment.
Career Highlights
Müller is affiliated with Julius-Maximilians-Universität Würzburg, where he conducts his research and development. His work has garnered attention in the scientific community, contributing to advancements in therapeutic applications.
Collaborations
Müller collaborates with notable colleagues, including Jörg Wischhusen and Markus Junker. Their combined expertise enhances the research efforts in the field of monoclonal antibodies.
Conclusion
Thomas Müller is a prominent figure in the realm of biotechnology, particularly known for his work on monoclonal antibodies targeting GDF-15. His innovative contributions continue to impact cancer research and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile